![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Active Filter(s):
Details:
Agreement will facilitate the full-scale local production of the Sputnik V vaccine in India and to supply our international partners globally.
Lead Product(s): Gam-COVID-Vac
Therapeutic Area: Infections and Infectious Diseases Product Name: Sputnik V
Highest Development Status: Approved Product Type: Vaccine
Partner/Sponsor/Collaborator: The Russian Direct Investment Fund
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership March 22, 2021